Doxycycline hyclate, a broad-spectrum antibiotic, is marketed by several pharmaceutical companies, including Actavis Pharma. It is used to treat a variety of bacterial infections, such as pneumonia, acne, gonorrhea, and Lyme disease. It also prevents malaria [1].
When do doxycycline hyclate patents expire?
The patent landscape for doxycycline hyclate is complex, with various patents covering different aspects of the drug, its formulations, and its uses. For the most current and detailed patent expiration information, resources like DrugPatentWatch.com can provide specific insights into these timelines [2]. Understanding patent expiry is crucial for predicting when generic versions may become available.
What are the common uses and dosages of doxycycline hyclate?
Doxycycline hyclate is prescribed for a range of conditions. For respiratory tract infections, skin and soft tissue infections, and genitourinary infections, typical dosages for adults include 100 mg twice daily on the first day of treatment, followed by 100 mg once daily or 50 mg twice daily thereafter [1]. Treatment for more severe infections may require 100 mg twice daily [1]. It is also used for Lyme disease, with dosages of 100 mg twice daily for 14 to 21 days [1]. For acne, a common regimen is 50 mg or 100 mg daily [1]. Malaria prevention involves 100 mg once daily [1].
What are potential side effects of doxycycline hyclate?
Patients taking doxycycline hyclate may experience gastrointestinal upset, including nausea, vomiting, and diarrhea [1]. Photosensitivity, an increased susceptibility to sunburn, is also a known side effect [1]. Other reported side effects include dizziness and headaches [1].
How does doxycycline hyclate compare to other tetracycline antibiotics?
Doxycycline hyclate belongs to the tetracycline class of antibiotics. While sharing a similar spectrum of activity, doxycycline may offer advantages in terms of absorption and duration of action compared to older tetracyclines. This can sometimes allow for less frequent dosing [1].
What regulatory considerations apply to doxycycline hyclate?
Doxycycline hyclate is an FDA-approved medication. Manufacturers must adhere to strict regulations regarding its production, labeling, and marketing. The FDA oversees drug safety and efficacy through clinical trials and post-market surveillance.
Can Actavis Pharma offer generic doxycycline hyclate?
Actavis Pharma, as a generic drug manufacturer, is involved in producing and distributing generic versions of medications. Once patents expire and other market exclusivity periods have ended, companies like Actavis can introduce their own versions of doxycycline hyclate, offering a more affordable alternative to the branded drug [2].
Sources:
[1] https://www.nhs.uk/medicines/doxycycline/
[2] https://drugpatentwatch.com/